How You Should Be Choosing Your Stocks

From Vantage Point | Ad

Grab your seat at our complimentary LIVE, interactive masterclass for traders. It’s your chance to finally learn how to pick the right stocks and find the best trades. We’ll also be diving into market forecasting and revealing under-the-radar stocks we believe have significant potential in Q2.

Click here now to join and get access to our forecasting.

BGNE Insider Trading (BeiGene)

Insider Trading Chart
Insider Trading History
Frequently Asked Questions
About

Insider Ownership Percentage: 8.90%

Insider Buying (Last 12 Months): $57,249,519.74

Insider Selling (Last 12 Months): $86,711,356.50

BeiGene Insider Trading History Chart

BeiGene Share Price & Price History

^$137.32

▲ +5.65 (4.29%)

As of 05/20/2022 05:00 PM ET

Days: 30 | 90 | 365

Warning: The Last Value Play Gone After August?

From Oxford Club | Ad

In this market...There's ONE STOCK (priced at just under $2) that could be $20 and STILL be a bargain. It brought in more income – including equity sales - in the last 12 months than Disney, Square or Tesla.

But a key announcement in August could send this stock rocketing skyward

Get the Details Now.

BeiGene Insider Trading History

Transaction Date	Insider Name	Title	Buy/Sell	Number of Shares	Average Share Price	Total Transaction	Shares Held After Transaction
5/5/2022	Xiaobin Wu	COO	Sell	6,725	$164.35	$1,105,253.75
12/14/2021	Jane Huang	CMO	Sell	1,500	$278.14	$417,210.00
12/1/2021	Jane Huang	CMO	Sell	1,049	$359.86	$377,493.14
11/17/2021	Jane Huang	CMO	Sell	1,500	$381.34	$572,010.00
10/19/2021	Jane Huang	CMO	Sell	1,500	$372.78	$559,170.00
9/24/2021	Ltd. Beigene	Major Shareholder	Buy	2,543,800	$2.85	$7,249,830.00
9/20/2021	Jane Huang	CMO	Sell	6,000	$397.96	$2,387,760.00
9/14/2021	John Oyler	CEO	Sell	195,477	$93.87	$18,349,425.99	2,267,161
9/13/2021	Jane Huang	CMO	Sell	12,901	$358.14	$4,620,364.14	145,235
9/10/2021	Amgen Inc	Major Shareholder	Buy	165,529	$302.06	$49,999,689.74
9/2/2021	John Oyler	CEO	Sell	24,499	$328.21	$8,040,816.79	3,694,720
9/1/2021	Jane Huang	CMO	Sell	542	$310.53	$168,307.26	305,824
8/31/2021	John Oyler	CEO	Sell	111,081	$110.13	$12,233,350.53
8/4/2021	John Oyler	CEO	Sell	80,847	$150.97	$12,205,471.59	4,385,979
7/22/2021	John Oyler	CEO	Sell	69,216	$71.82	$4,971,093.12	5,849,945
7/20/2021	John Oyler	CEO	Sell	43,695	$132.26	$5,779,100.70	5,849,945
7/15/2021	Jane Huang	CMO	Sell	21,000	$332.42	$6,980,820.00	298,661
7/7/2021	John Oyler	CEO	Sell	300	$325.23	$97,569.00
7/6/2021	Xiaobin Wu	COO	Sell	10,180	$325.53	$3,313,895.40	1,081,389
7/1/2021	Julia Aijun Wang	CFO	Sell	308	$349.06	$107,510.48
6/28/2021	Howard Liang	CFO	Sell	446	$365.00	$162,790.00	1,553,149
6/28/2021	Lai Wang	Insider	Sell	455	$362.48	$164,928.40
6/18/2021	Xiaobin Wu	COO	Sell	1,156	$330.93	$382,555.08
6/9/2021	Timothy Yung-Cheng Chen	Director	Sell	3,164	$351.35	$1,111,671.40	3,164
6/7/2021	Howard Liang	CFO	Sell	650	$354.16	$230,204.00	1,565,265
6/7/2021	Jane Huang	CMO	Sell	603	$351.55	$211,984.65	284,933
6/7/2021	Lai Wang	Insider	Sell	656	$354.26	$232,394.56	195,455
6/7/2021	Xiaobin Wu	COO	Sell	3,398	$352.54	$1,197,930.92	1,150,757
6/1/2021	Jane Huang	CMO	Sell	540	$362.64	$195,825.60	292,772
5/28/2021	Jane Huang	CMO	Sell	1,500	$356.30	$534,450.00	292,772
5/10/2021	Xiaodong Wang	Insider	Sell	3,394	$300.46	$1,019,761.24	5,747,271
5/3/2021	Xiaobin Wu	COO	Sell	6,715	$343.00	$2,303,245.00
4/29/2021	Jane Huang	CMO	Sell	1,500	$354.92	$532,380.00	285,583
3/29/2021	Jane Huang	CMO	Sell	1,500	$324.00	$486,000.00	285,583
1/29/2021	Jane Huang	CMO	Sell	1,500	$322.99	$484,485.00	285,583
1/15/2021	Howard Liang	CFO	Sell	12,600	$344.90	$4,345,740.00	1,573,715
1/4/2021	Bros. Advisors Lp Baker	Director	Sell	121,154	$220.50	$26,714,457.00
12/29/2020	Jane Huang	CMO	Sell	1,500	$249.13	$373,695.00	285,583
12/14/2020	Howard Liang	CFO	Sell	91,900	$229.04	$21,048,776.00	1,573,715
11/30/2020	Jane Huang	CMO	Sell	1,500	$267.82	$401,730.00	285,583
10/29/2020	Jane Huang	CMO	Sell	1,500	$300.06	$450,090.00	285,583
10/16/2020	Xiaodong Wang	Insider	Sell	5,000	$320.00	$1,600,000.00	7,201,009
10/5/2020	Howard Liang	CFO	Sell	14,000	$299.60	$4,194,400.00	168,415
10/5/2020	Xiaodong Wang	Insider	Sell	5,000	$300.00	$1,500,000.00	7,201,009
9/29/2020	Jane Huang	CMO	Sell	1,500	$280.38	$420,570.00	285,583
9/29/2020	John Oyler	CEO	Sell	54,303	$280.39	$15,226,018.17	8,927,570
9/25/2020	Xiaodong Wang	Insider	Sell	5,000	$280.42	$1,402,100.00	7,201,009
9/17/2020	Xiaodong Wang	Insider	Sell	5,000	$260.27	$1,301,350.00	7,201,009
9/16/2020	John Oyler	CEO	Sell	27,275	$254.77	$6,948,851.75	9,633,509
9/14/2020	Howard Liang	CFO	Sell	14,000	$250.27	$3,503,780.00	168,415
9/14/2020	John Oyler	CEO	Sell	19,739	$250.25	$4,939,684.75	9,633,509
9/3/2020	Jane Huang	CMO	Sell	3,128	$233.07	$729,042.96	285,583
9/2/2020	John Oyler	CEO	Sell	61,042	$233.21	$14,235,604.82	10,689,473
8/31/2020	John Oyler	CEO	Sell	12,961	$240.86	$3,121,786.46	10,689,473
8/28/2020	Jane Huang	CMO	Sell	3,000	$242.21	$726,630.00	326,247
8/21/2020	John Oyler	CEO	Sell	40,788	$240.19	$9,796,869.72	11,483,019
8/19/2020	John Oyler	CEO	Sell	29,866	$234.56	$7,005,368.96	11,483,019
8/14/2020	John Oyler	CEO	Sell	8,705	$211.15	$1,838,060.75	12,681,320
8/12/2020	John Oyler	CEO	Sell	19,820	$212.10	$4,203,822.00	12,681,320
8/11/2020	Timothy Yung-Cheng Chen	Director	Sell	1,903	$213.04	$405,415.12	2,200
8/10/2020	Xiaodong Wang	Insider	Sell	4,000	$211.06	$844,240.00	7,201,009
8/5/2020	John Oyler	CEO	Sell	17,254	$223.27	$3,852,300.58	13,239,904
8/3/2020	John Oyler	CEO	Sell	25,176	$221.78	$5,583,533.28	13,464,206
7/29/2020	Jane Huang	CMO	Sell	3,000	$209.93	$629,790.00	326,247
7/22/2020	John Oyler	CEO	Sell	27,748	$238.34	$6,613,458.32	13,991,473
7/20/2020	John Oyler	CEO	Sell	28,762	$251.85	$7,243,709.70	14,352,197
7/20/2020	Xiaobin Wu	Insider	Sell	3,300	$249.22	$822,426.00	1,423,562
7/17/2020	Xiaobin Wu	Insider	Sell	700	$245.74	$172,018.00	1,423,562
7/15/2020	Xiaobin Wu	Insider	Sell	2,700	$241.11	$650,997.00	1,466,462
7/13/2020	Xiaobin Wu	Insider	Sell	3,000	$220.00	$660,000.00	1,466,462
7/8/2020	John Oyler	CEO	Sell	17,529	$201.39	$3,530,165.31	15,069,472
7/7/2020	Jane Huang	CMO	Sell	3,921	$200.00	$784,200.00	326,247
7/7/2020	Xiaodong Wang	Insider	Sell	6,000	$200.00	$1,200,000.00	7,267,569
7/6/2020	John Oyler	CEO	Sell	17,362	$197.11	$3,422,223.82	15,069,472
7/1/2020	John Oyler	CEO	Sell	3,816	$191.57	$731,031.12	15,770,354
6/29/2020	Howard Liang	CFO	Sell	300	$191.23	$57,369.00	168,415
6/29/2020	Jane Huang	CMO	Sell	1,935	$190.83	$369,256.05	326,247
6/29/2020	John Oyler	CEO	Sell	1,435	$192.60	$276,381.00	15,770,354
6/26/2020	Jane Huang	CMO	Sell	2,079	$200.29	$416,402.91	326,247
6/24/2020	John Oyler	CEO	Sell	14,381	$187.34	$2,694,136.54	15,838,617
6/22/2020	John Oyler	CEO	Sell	10,281	$182.43	$1,875,562.83	15,838,617
6/22/2020	Xiaodong Wang	Insider	Sell	5,000	$181.33	$906,650.00	7,330,580
6/8/2020	Howard Liang	CFO	Sell	453	$170.84	$77,390.52	116,428
6/8/2020	Jane Huang	CMO	Sell	631	$170.84	$107,800.04	283,464
6/8/2020	Xiaobin Wu	Insider	Sell	2,800	$170.83	$478,324.00	1,380,415
5/29/2020	Jane Huang	CMO	Sell	1,500	$163.86	$245,790.00	291,667
5/19/2020	Donald W. Glazer	Director	Sell	10,000	$169.84	$1,698,400.00	3,497,678
5/1/2020	John Oyler	CEO	Sell	4,635	$141.43	$655,528.05	16,366,833
5/1/2020	Xiaobin Wu	Insider	Sell	7,024	$141.33	$992,701.92
4/29/2020	Jane Huang	CMO	Sell	1,500	$162.30	$243,450.00	291,667
4/16/2020	Jane Huang	CMO	Sell	1,500	$160.00	$240,000.00	291,667
3/4/2020	Xiaodong Wang	Insider	Sell	5,000	$157.14	$785,700.00	7,395,580
1/21/2020	Jane Huang	CMO	Sell	1,500	$170.69	$256,035.00	291,667
12/17/2019	John Oyler	CEO	Sell	62,259	$160.62	$10,000,040.58	16,411,788
12/16/2019	Jane Huang	CMO	Sell	1,500	$165.14	$247,710.00	291,667
11/18/2019	Howard Liang	CFO	Sell	25,000	$194.34	$4,858,500.00	122,317
11/18/2019	Jane Huang	CMO	Sell	1,500	$194.49	$291,735.00	291,667
11/14/2019	Xiaodong Wang	Insider	Sell	8,504	$193.31	$1,643,908.24	7,460,580
11/5/2019	Timothy Yung-Cheng Chen	Director	Sell	3,800	$189.15	$718,770.00	4,000
11/4/2019	Jane Huang	CMO	Sell	32,900	$190.46	$6,266,134.00	291,667
11/4/2019	Xiaodong Wang	Insider	Sell	1,000	$190.00	$190,000.00	7,585,628
11/1/2019	Xiaodong Wang	Insider	Sell	1,000	$170.00	$170,000.00	7,585,628
9/3/2019	Jane Huang	CMO	Sell	2,862	$144.45	$413,415.90	291,667
8/23/2019	Timothy Yung-Cheng Chen	Director	Sell	8,614	$144.96	$1,248,685.44
8/12/2019	Jane Huang	CMO	Sell	2,500	$134.74	$336,850.00	328,873
7/29/2019	Jane Huang	CMO	Sell	10,130	$134.54	$1,362,890.20	328,873
7/8/2019	John Oyler	CEO	Sell	3,106	$126.87	$394,058.22	17,221,155
7/1/2019	Xiaodong Wang	Insider	Sell	4,847	$126.46	$612,951.62	7,611,628
6/27/2019	Howard Liang	CFO	Sell	5,876	$9.47	$55,645.72	122,317
6/27/2019	Jane Huang	CMO	Sell	430	$124.52	$53,543.60	3

Warning: The Last Value Play Gone After August?

From Oxford Club | Ad

Get the Details Now.

SEC Filings (Institutional Ownership Changes) for BeiGene (NASDAQ:BGNE)

Institutional Buying and Selling by Quarter

BeiGene Institutional Trading History

Reporting Date	Hedge Fund	Shares Held	Market Value	% of Portfolio	Quarterly Change in Shares	Ownership in Company
5/20/2022	International Biotechnology Trust PLC	15,700	$11.40M	2.6%	-21.5%	0.015%
5/20/2022	The Manufacturers Life Insurance Company	20,175	$4.01M	0.0%	+155.4%	0.020%
5/19/2022	Capital International Sarl	172,972	$32.62M	1.6%	+38.3%	0.168%
5/19/2022	Capital Group International Inc. CA	1,140,960	$215.19M	2.4%	+14.1%	1.106%
5/19/2022	Capital International Investors	7,055,295	$1.34B	0.3%	+11.2%	6.838%
5/18/2022	BNP Paribas Arbitrage SA	73,973	$13.95M	0.0%	-16.9%	0.072%
5/17/2022	Advisors Asset Management Inc.	1,244	$0.24M	0.0%	+26.7%	0.001%
5/17/2022	Royal Bank of Canada	74,053	$13.97M	0.0%	+48.0%	0.072%
5/17/2022	First Republic Investment Management Inc.	6,882	$1.30M	0.0%	+43.9%	0.007%
5/16/2022	California State Teachers Retirement System	9,380	$1.77M	0.0%	-2.1%	0.009%
5/16/2022	Goldman Sachs Group Inc.	238,676	$45.01M	0.0%	+26.7%	0.232%
5/16/2022	Wellington Management Group LLP	75,004	$14.15M	0.0%	-90.0%	0.073%
5/16/2022	State Street Corp	835,546	$157.58M	0.0%	-8.1%	0.814%
5/16/2022	United Capital Financial Advisers LLC	2,960	$0.56M	0.0%	+5.1%	0.003%
5/16/2022	Vident Investment Advisory LLC	5,494	$1.04M	0.0%	+10.4%	0.005%
5/16/2022	Capital Group Private Client Services Inc.	275,197	$51.90M	0.6%	+74.2%	0.267%
5/16/2022	Invesco Ltd.	2,724,261	$513.80M	0.1%	-9.3%	2.653%
5/16/2022	UBS Group AG	84,572	$15.95M	0.0%	+90.4%	0.082%
5/16/2022	Hsbc Holdings PLC	83,839	$15.81M	0.0%	+10.8%	0.082%
5/13/2022	Nan Fung Group Holdings Ltd	12,022	$2.27M	1.1%	+7.3%	0.012%
5/13/2022	Northern Trust Corp	106,803	$20.14M	0.0%	-6.5%	0.104%
5/13/2022	Dai Ichi Life Insurance Company Ltd	2,100	$0.40M	0.0%	-25.0%	0.002%
5/13/2022	Caisse DE Depot ET Placement DU Quebec	4,656	$0.88M	0.0%	-42.4%	0.005%
5/13/2022	Parkwood LLC	7,017	$1.32M	0.2%	+4.4%	0.007%
5/13/2022	First Trust Advisors LP	2,134	$0.40M	0.0%	-4.5%	0.002%
5/13/2022	USS Investment Management Ltd	105,897	$19.99M	0.2%	-51.1%	0.103%
5/13/2022	Bridgewater Associates LP	383,818	$72.39M	0.3%	+67.3%	0.374%
5/13/2022	Tekla Capital Management LLC	51,018	$9.62M	0.3%	-20.0%	0.050%
5/13/2022	Baird Financial Group Inc.	93,602	$17.65M	0.0%	+10.6%	0.091%
5/13/2022	Vanguard Group Inc.	83,745	$15.79M	0.0%	+5.3%	0.082%
5/13/2022	Canada Pension Plan Investment Board	38,200	$7.21M	0.0%	N/A	0.037%
5/13/2022	Aviva PLC	21,749	$4.10M	0.0%	+0.9%	0.021%
5/13/2022	Dimensional Fund Advisors LP	15,368	$2.94M	0.0%	+15.4%	0.015%
5/12/2022	BRITISH COLUMBIA INVESTMENT MANAGEMENT Corp	20,475	$3.86M	0.0%	+6.1%	0.020%
5/12/2022	HAP Trading LLC	11,152	$2.10M	0.1%	N/A	0.011%
5/12/2022	BNP PARIBAS ASSET MANAGEMENT Holding S.A.	166,884	$31.47M	0.1%	+0.6%	0.163%
5/12/2022	Great West Life Assurance Co. Can	68,206	$13.43M	0.0%	+9.3%	0.066%
5/12/2022	APG Asset Management N.V.	5,331	$0.90M	0.0%	-7.0%	0.005%
5/12/2022	BlackRock Inc.	2,699,444	$509.11M	0.0%	+3.8%	2.629%
5/12/2022	Panagora Asset Management Inc.	5,195	$0.98M	0.0%	+3.7%	0.005%
5/12/2022	Artal Group S.A.	665,000	$125.42M	5.3%	-1.5%	0.648%
5/12/2022	Bank of Montreal Can	14,571	$3M	0.0%	+19.7%	0.014%
5/12/2022	Citigroup Inc.	18,006	$3.40M	0.0%	-34.8%	0.018%
5/12/2022	Mitsubishi UFJ Trust & Banking Corp	127,182	$23.99M	0.1%	-6.2%	0.124%
5/12/2022	Connor Clark & Lunn Investment Management Ltd.	4,639	$0.88M	0.0%	+275.6%	0.005%
5/12/2022	Private Advisor Group LLC	1,156	$0.22M	0.0%	-17.4%	0.001%
5/12/2022	Oppenheimer Asset Management Inc.	11,947	$2.25M	0.0%	-9.8%	0.012%
5/11/2022	US Bancorp DE	2,334	$0.44M	0.0%	-28.3%	0.002%
5/11/2022	American Century Companies Inc.	3,458	$0.65M	0.0%	+7.9%	0.003%
5/11/2022	Bank of New York Mellon Corp	55,199	$10.41M	0.0%	+0.6%	0.054%
5/11/2022	Crossmark Global Holdings Inc.	2,912	$0.55M	0.0%	+5.7%	0.003%
5/11/2022	Krane Funds Advisors LLC	22,952	$4.33M	0.2%	+9.4%	0.022%
5/11/2022	Handelsbanken Fonder AB	17,500	$3.30M	0.0%	+6.1%	0.017%
5/11/2022	Raymond James & Associates	15,273	$2.88M	0.0%	+24.9%	0.015%
5/11/2022	Primecap Management Co. CA	3,708,804	$699.48M	0.5%	-0.2%	3.612%
5/11/2022	Flossbach Von Storch AG	4,500	$0.85M	0.0%	-18.2%	0.004%
5/11/2022	NN Investment Partners Holdings N.V.	24,800	$4.68M	0.0%	+45.0%	0.024%
5/11/2022	Skandinaviska Enskilda Banken AB publ	10,477	$1.98M	0.0%	-7.5%	0.010%
5/11/2022	JPMorgan Chase & Co.	116,398	$21.95M	0.0%	-14.2%	0.113%
5/10/2022	Sectoral Asset Management Inc.	4,580	$0.86M	0.2%	-4.2%	0.004%
5/10/2022	Profund Advisors LLC	8,527	$1.61M	0.1%	+64.7%	0.008%
5/10/2022	ProShare Advisors LLC	5,152	$0.97M	0.0%	-26.3%	0.005%
5/10/2022	TD Asset Management Inc.	23,965	$4.52M	0.0%	-2.3%	0.023%
5/10/2022	Aaron Wealth Advisors LLC	48,470	$0.26M	0.0%	N/A	0.047%
5/10/2022	Van ECK Associates Corp	93,329	$17.60M	0.0%	+83.3%	0.091%
5/10/2022	Mirae Asset Global Investments Co. Ltd.	98,639	$18.60M	0.0%	-13.8%	0.096%
5/10/2022	Edmond DE Rothschild Holding S.A.	65,000	$12.26M	0.3%	+25.0%	0.063%
5/10/2022	Capricorn Fund Managers Ltd	2,408	$0.45M	0.1%	N/A	0.002%
5/10/2022	Privium Fund Management B.V.	15,000	$2.83M	0.6%	N/A	0.015%
5/9/2022	Fiera Capital Corp	7,868	$1.48M	0.0%	-94.4%	0.008%
5/9/2022	Swiss National Bank	128,885	$24.31M	0.0%	+14.1%	0.126%
5/9/2022	Teacher Retirement System of Texas	41,135	$7.76M	0.0%	+31.4%	0.040%
5/9/2022	Mitsubishi UFJ Kokusai Asset Management Co. Ltd.	16,071	$3.03M	0.0%	+11.7%	0.016%
5/9/2022	Banque Cantonale Vaudoise	172	$32K	0.0%	-85.2%	0.000%
5/6/2022	AIA Group Ltd	3,415	$0.64M	0.0%	+229.6%	0.003%
5/6/2022	KBC Group NV	14,192	$2.68M	0.0%	+0.9%	0.014%
5/6/2022	Zeal Asset Management Ltd	194,838	$38.10M	49.7%	+266.3%	0.190%
5/6/2022	IFM Investors Pty Ltd	1,729	$0.33M	0.0%	N/A	0.002%
5/5/2022	Matthews International Capital Management LLC	177,592	$33.49M	4.6%	-23.7%	0.173%
5/5/2022	Baillie Gifford & Co.	4,102,968	$773.82M	0.5%	-0.5%	3.997%
5/5/2022	New York State Common Retirement Fund	66,135	$12.47M	0.0%	-36.2%	0.064%
5/5/2022	Russell Investments Group Ltd.	6,189	$1.17M	0.0%	-7.7%	0.006%
5/4/2022	California Public Employees Retirement System	199,967	$37.71M	0.0%	-9.4%	0.195%
5/4/2022	Envestnet Asset Management Inc.	24,063	$4.54M	0.0%	+6.6%	0.023%
5/4/2022	Shell Asset Management Co.	9,226	$1.74M	0.0%	-23.9%	0.009%
5/3/2022	FDx Advisors Inc.	2,319	$0.44M	0.0%	-13.1%	0.002%
5/2/2022	LVW Advisors LLC	1,725	$0.33M	0.1%	-4.1%	0.002%
4/29/2022	SG Americas Securities LLC	33,192	$6.26M	0.0%	-2.6%	0.032%
4/29/2022	Daiwa Securities Group Inc.	145	$27K	0.0%	-93.5%	0.000%
4/28/2022	DekaBank Deutsche Girozentrale	31,279	$12.71M	0.0%	-2.5%	0.030%
4/27/2022	Vestmark Advisory Solutions Inc.	1,699	$0.32M	0.0%	+27.1%	0.002%
4/27/2022	Sumitomo Mitsui Trust Holdings Inc.	109,345	$20.62M	0.0%	+2.8%	0.107%
4/26/2022	Kestra Advisory Services LLC	2,243	$0.42M	0.0%	+11.0%	0.002%
4/25/2022	Long Corridor Asset Management Ltd	13,600	$2.57M	3.1%	+36.0%	0.013%
4/21/2022	Zurcher Kantonalbank Zurich Cantonalbank	20,944	$3.95M	0.0%	+23.2%	0.020%
4/21/2022	Lindbrook Capital LLC	207	$39K	0.0%	-26.6%	0.000%
4/20/2022	Koshinski Asset Management Inc.	242	$46K	0.0%	+139.6%	0.000%
4/16/2022	IFM Investors Pty Ltd	1,729	$0.33M	0.0%	N/A	0.002%
4/13/2022	MEAG MUNICH ERGO Kapitalanlagegesellschaft mbH	700	$0.13M	0.0%	-90.3%	0.001%
4/12/2022	E Fund Management Hong Kong Co. Ltd.	27,501	$5.07M	3.2%	+137.7%	0.027%

Data available starting January 2016

BeiGene, Ltd. discovers, develops, manufactures, and commercializes medicines for cancer therapeutics in the People's Republic of China, the United States, and internationally. Its products include BRUKINSA to treat relapsed/refractory (R/R) mantle cell lymphoma; Tislelizumab to treat R/R classical Hodgkin's lymphoma; REVLIMID to treat multiple myeloma; VIDAZA to treat myelodysplastic syndromes, chronic myelomonocyte leukemia, and acute myeloid leukemia; XGEVA to treat giant cell tumor of bone; BLINCYTO to treat acute lymphoblastic leukemia; KYPROLIS to treat R/R multiple myeloma; SYLVANT to treat idiopathic multicentric castleman disease; QARZIBA to treat neuroblastoma; Pamiparib for the treatment of various solid tumors; and Pobevcy to treat metastatic colorectal cancer, liver cancer, and non-small cell lung cancer (NSCLC). The company's clinical stage drug candidates comprise Zanubrutinib, a BTK inhibitor to treat lymphomas; Tislelizumab, an anti-PD-1 antibody to treat solid and hematological cancers; Lifirafenib and BGB-3245 to treat melanoma, NSCLC, and endometrial cancer; and Sitravatinib, a multi-kinase inhibitor to treat NSCLC, melanoma, and other solid tumors. Its clinical stage drug candidates also include BGB-A333, a PD-L1 inhibitor to treat various solid tumors; Ociperlimab, a TIGIT inhibitor to treat various solid tumors; BGB-11417, a small molecule Bcl-2 inhibitor to treat mature B-cell malignancies; BGB-A445, an OX40 agonist antibody to treat solid tumors; Zanidatamab, a bispecific HER2 inhibitor to treat breast and gastric cancer; BGB-A425, a T-cell immunoglobulin and mucin-domain containing-3 inhibitor to treat various solid tumors; and BGB-15025, a small molecule inhibitor of HPK1. BeiGene, Ltd. has strategic collaborations with Shoreline Biosciences, Inc., Amgen Inc., Novartis AG, and Bristol Myers Squibb company. BeiGene, Ltd. was incorporated in 2010 and is headquartered in Beijing, China.

Today's Range

Now: $137.32

$129.30

$139.45

50 Day Range

MA: $171.80

$121.11

$216.05

52 Week Range

Now: $137.32

$120.00

$426.56

Volume

259,742 shs

Average Volume

296,854 shs

Market Capitalization

$14.17 billion

P/E Ratio

N/A

Dividend Yield

N/A

Beta

0.85

Who are the company insiders with the largest holdings of BeiGene?: BeiGene's top insider investors include:
John Oyler (CEO)
Xiaodong Wang (Insider)
Howard Liang (CFO)
Xiaobin Wu (Insider)
Xiaobin Wu (COO)
Jane Huang (CMO)
Lai Wang (Insider)
Timothy Yung-Cheng Chen (Director)
Amgen Inc (Major Shareholder)
Bros Advisors Lp Baker (Director)
Julia Aijun Wang (CFO)
Ltd Beigene (Major Shareholder)
Learn More about top insider investors at BeiGene.
Who are the major institutional investors of BeiGene?: BeiGene's top institutional shareholders include:
Capital International Investors — 6.84%
Baillie Gifford & Co. — 4.00%
Primecap Management Co. CA — 3.61%
Invesco Ltd. — 2.65%
BlackRock Inc. — 2.63%
Capital Group International Inc. CA — 1.11%
Learn More about top institutional investors of BeiGene stock.
Which major investors are selling BeiGene stock?: During the previous quarter, BGNE stock was sold by these institutional investors:
Wellington Management Group LLP
Invesco Ltd.
Fiera Capital Corp
USS Investment Management Ltd
State Street Corp
Matthews International Capital Management LLC
New York State Common Retirement Fund
Baillie Gifford & Co.
During the previous year, company insiders that have sold BeiGene company stock include:
John Oyler (CEO)
Xiaodong Wang (Insider)
Howard Liang (CFO)
Xiaobin Wu (Insider)
Xiaobin Wu (COO)
Jane Huang (CMO)
Lai Wang (Insider)
Learn More investors selling BeiGene stock.
Which major investors are buying BeiGene stock?: During the previous quarter, BGNE stock was acquired by institutional investors including:
Capital International Investors
Bridgewater Associates LP
Zeal Asset Management Ltd
Capital Group International Inc. CA
Capital Group Private Client Services Inc.
BlackRock Inc.
Goldman Sachs Group Inc.
Aaron Wealth Advisors LLC
During the previous year, these company insiders have bought BeiGene stock:
John Oyler (CEO)
Xiaodong Wang (Insider)
Learn More investors buying BeiGene stock.

Warning: The Last Value Play Gone After August?

From Oxford Club | Ad

Get the Details Now.

BGNE Insider Trading (BeiGene)

BeiGene Insider Trading History Chart

BeiGene Share Price & Price History

BeiGene Insider Trading History

SEC Filings (Institutional Ownership Changes) for BeiGene (NASDAQ:BGNE)

Institutional Buying and Selling by Quarter

BeiGene Institutional Trading History

Today's Range

50 Day Range

52 Week Range

Volume

Average Volume

Market Capitalization

P/E Ratio

Dividend Yield

Beta

Who are the company insiders with the largest holdings of BeiGene?

Who are the major institutional investors of BeiGene?

Which major investors are selling BeiGene stock?

Which major investors are buying BeiGene stock?